Tibet Cheezheng Tibetan Medicine Co., Ltd. Stock price

Equities

002287

CNE100000FM9

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-02-19 pm EST 5-day change 1st Jan Change
20.12 CNY +0.25% Intraday chart for Tibet Cheezheng Tibetan Medicine Co., Ltd. +1.51% -10.54%
Sales 2021 1.77B 246M Sales 2022 2.04B 284M Capitalization 12.06B 1.68B
Net income 2021 716M 99.6M Net income 2022 472M 65.66M EV / Sales 2021 8.83 x
Net cash position 2021 506M 70.4M Net cash position 2022 505M 70.23M EV / Sales 2022 5.65 x
P/E ratio 2021
22.6 x
P/E ratio 2022
25.7 x
Employees 2,974
Yield 2021
1.93%
Yield 2022
1.71%
Free-Float 10.75%
More Fundamentals * Assessed data
Dynamic Chart
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 20, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Year 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Tibet Cheezheng Tibetan Medicine Logs 34.1% Drop in 2022 Profit MT
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Announces Final Cash Dividend on A Shares for 2021, Payable on 19 July 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Approves Cash Dividend for the Financial Year 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Tibet Cheezheng Tibetan Medicine Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day+0.25%
1 week+1.51%
Current month+6.51%
1 month-0.94%
3 months-15.67%
6 months-14.24%
Current year-10.54%
More quotes
1 week
19.70
Extreme 19.7
20.87
1 month
16.27
Extreme 16.27
20.87
Current year
16.27
Extreme 16.27
23.00
1 year
16.27
Extreme 16.27
27.69
3 years
16.27
Extreme 16.27
35.50
5 years
16.27
Extreme 16.27
45.23
10 years
14.64
Extreme 14.6418
50.30
More quotes
Managers TitleAgeSince
Director of Finance/CFO 54 18-08-28
President 60 09-01-23
Chairman 71 07-10-07
Members of the board TitleAgeSince
Chairman 71 07-10-07
Director/Board Member 62 22-07-12
Director/Board Member 48 20-12-20
More insiders
Date Price Change Volume
24-02-20 20.12 +0.25% 1,613,171

End-of-day quote Shenzhen S.E., February 19, 2024

More quotes
Tibet Cheezheng Tibetan Medicine Co., Ltd is a China-based company, principally engaged in the research, development, manufacture and distribution of Tibetan medicines. The Company primarily offers medicines under emplastrum, ointment, granule, crude drugs and others. The Company's products include external pain relieving series, including Cheezheng Xiaotong emplastrum, Qingpeng ointment and Baimai ointment, as well as oral medicine series. The Company distributes its products within domestic market and to overseas markets.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd. - Shenzhen S.E.
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer